Results 211 to 220 of about 883,314 (350)
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta+10 more
wiley +1 more source
Hemoglobin in cardiogenic shock: the lower, the poorer survival. [PDF]
Cherbi M+13 more
europepmc +1 more source
Efficacy of balloon valvuloplasty in patients with critical aortic stenosis and cardiogenic shock—the role of shock duration [PDF]
Arnd B. Buchwald+4 more
openalex +1 more source
Acute myocarditis according to age: Presentation, management and early outcomes
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty+25 more
wiley +1 more source
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna+18 more
wiley +1 more source
Cardiogenic Shock as the Initial Manifestation of Thyrotoxicosis. [PDF]
Soria BX+9 more
europepmc +1 more source
Application of “double bridge mechanical” resuscitation for profound cardiogenic shock leading to cardiac transplantation [PDF]
Frank W. Bowen+8 more
openalex +1 more source